Tsukuba, Japan

Akira Togayachi

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Ibaraki, JP (2017 - 2019)
  • Tsukuba, JP (2007 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Akira Togayachi: Innovator in Antibody Detection and Lung Cancer Markers

Introduction

Akira Togayachi is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the fields of immunology and oncology. With a total of 10 patents to his name, Togayachi has developed innovative methods and systems that enhance the detection and diagnosis of diseases, particularly hepatitis and lung cancer.

Latest Patents

Among his latest patents, Togayachi has created a method for efficiently inducing antibodies and a detection system for hepatitis virus. This examination system recognizes a glycosylated antigen in Dane particles of the hepatitis B virus (HBV) and includes a neutralizing antibody that exhibits infection-inhibiting activity. His research elucidated the association of Dane particles with specific glycan structures, leading to the construction of a new detection system for infectious hepatitis B virus particles. Additionally, he has developed a lung cancer differential marker that allows for convenient and highly sensitive diagnosis of lung cancer without solely relying on protein expression levels. This invention also includes a glycan marker capable of distinguishing between histological types of lung cancer.

Career Highlights

Togayachi has worked with esteemed institutions such as the National Institute of Advanced Industrial Science and Technology and Tokyo Medical University. His work has significantly advanced the understanding and detection of critical health issues, showcasing his dedication to medical innovation.

Collaborations

Throughout his career, Togayachi has collaborated with notable colleagues, including Hisashi Narimatsu and Yuzuru Ikehara. These partnerships have contributed to the success and impact of his research.

Conclusion

Akira Togayachi's innovative work in antibody detection and lung cancer markers has made a substantial impact on medical diagnostics. His patents reflect a commitment to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…